EUVIMEDEUVIMED entdecken
Crossref

Early prediction of hypotheroidism following 131I treatment for Graves' disease

R Wilson, J H McKillop, E Black, C Jenkins, J A Thomson

European Journal of Nuclear Medicine · 1988-07 · 14 (4)

DOI: 10.1007/bf00257324 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine, 1988-07. Verfasst von R Wilson und 4 weiteren Autor:innen. Beteiligte Einrichtung: University Departments of Medicine, Royal Infirmary, Glasgow, UK. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntibodiesCarbimazoleFemaleGraves DiseaseHumansHypothyroidismIodine RadioisotopesMalePremedicationReceptors, ThyrotropinThyroid Function TestsTime Factors

Substanzen

AntibodiesIodine RadioisotopesReceptors, ThyrotropinCarbimazole

Autor:innen und Institutionen

  • University Departments of Medicine, Royal Infirmary, Glasgow, UK.

Zitieren

APA

Wilson, R., McKillop, J. H., Black, E., Jenkins, C., & Thomson, J. A. (1988). Early prediction of hypotheroidism following 131I treatment for Graves' disease. European Journal of Nuclear Medicine, 14(4). https://doi.org/10.1007/bf00257324

Vancouver

Wilson R, McKillop JH, Black E, Jenkins C, Thomson JA. Early prediction of hypotheroidism following 131I treatment for Graves' disease. European Journal of Nuclear Medicine. 1988;14(4). doi:10.1007/bf00257324

BibTeX
@article{Wilson1988,
  author = {Wilson, R and McKillop, J H and Black, E and Jenkins, C and Thomson, J A},
  title = {Early prediction of hypotheroidism following 131I treatment for Graves' disease},
  journal = {European Journal of Nuclear Medicine},
  year = {1988},
  volume = {14},
  number = {4},
  doi = {10.1007/bf00257324}
}
Kostenlos starten →